SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 98.784
AS - Asia 38.953
EU - Europa 36.979
SA - Sud America 6.138
Continente sconosciuto - Info sul continente non disponibili 2.053
AF - Africa 874
OC - Oceania 222
Totale 184.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 95.905
SG - Singapore 11.702
GB - Regno Unito 10.508
CN - Cina 9.185
IT - Italia 8.433
HK - Hong Kong 5.240
BR - Brasile 4.713
SE - Svezia 4.311
VN - Vietnam 4.218
FI - Finlandia 3.162
DE - Germania 2.534
BD - Bangladesh 2.453
UA - Ucraina 1.617
FR - Francia 1.517
RU - Federazione Russa 1.509
CA - Canada 1.341
TR - Turchia 1.318
KR - Corea 991
BG - Bulgaria 788
IN - India 706
ID - Indonesia 640
JP - Giappone 599
NL - Olanda 547
AR - Argentina 460
MX - Messico 441
IE - Irlanda 342
IQ - Iraq 331
ES - Italia 273
PK - Pakistan 239
BZ - Belize 234
PL - Polonia 218
EC - Ecuador 217
ZA - Sudafrica 205
AT - Austria 201
CO - Colombia 189
AU - Australia 188
AE - Emirati Arabi Uniti 177
CR - Costa Rica 158
CL - Cile 152
LT - Lituania 142
CH - Svizzera 132
VE - Venezuela 130
EG - Egitto 127
MA - Marocco 121
PH - Filippine 121
MY - Malesia 119
JM - Giamaica 111
TN - Tunisia 110
IL - Israele 103
SA - Arabia Saudita 99
HN - Honduras 98
BE - Belgio 95
PE - Perù 93
CZ - Repubblica Ceca 87
TH - Thailandia 85
GT - Guatemala 81
HU - Ungheria 80
UZ - Uzbekistan 79
PY - Paraguay 74
KE - Kenya 72
TT - Trinidad e Tobago 72
DZ - Algeria 68
JO - Giordania 66
TW - Taiwan 65
PT - Portogallo 63
DK - Danimarca 61
PR - Porto Rico 59
NP - Nepal 57
NI - Nicaragua 56
SV - El Salvador 54
IR - Iran 53
UY - Uruguay 53
EE - Estonia 51
RO - Romania 49
AZ - Azerbaigian 48
BO - Bolivia 47
GR - Grecia 44
DO - Repubblica Dominicana 43
AL - Albania 38
EU - Europa 38
SC - Seychelles 38
CW - ???statistics.table.value.countryCode.CW??? 36
RS - Serbia 36
NZ - Nuova Zelanda 29
KZ - Kazakistan 27
GP - Guadalupe 26
OM - Oman 26
BB - Barbados 25
SN - Senegal 25
BY - Bielorussia 24
BH - Bahrain 22
ET - Etiopia 22
LB - Libano 22
KG - Kirghizistan 21
KW - Kuwait 20
PA - Panama 18
LV - Lettonia 17
NO - Norvegia 17
SY - Repubblica araba siriana 17
PS - Palestinian Territory 16
Totale 181.690
Salva come PNG Salva come JPEG
Città #
Ashburn 10.848
Fairfield 8.615
Santa Clara 7.276
Singapore 7.221
Southend 6.696
Woodbridge 5.941
Hong Kong 5.157
San Jose 4.406
Houston 4.142
Chandler 3.412
Seattle 3.232
Council Bluffs 3.087
Wilmington 2.871
Jacksonville 2.792
Cambridge 2.643
Hefei 2.595
Helsinki 2.558
Ann Arbor 2.339
London 2.261
Dearborn 1.912
Beijing 1.833
Stockholm 1.821
New York 1.452
The Dalles 1.435
Modena 1.409
Los Angeles 1.358
Ho Chi Minh City 1.335
Nyköping 1.168
San Diego 1.031
Hanoi 988
Milan 963
Chicago 920
Seoul 910
Dallas 903
Princeton 805
Buffalo 763
Sofia 751
Lauterbourg 711
Columbus 594
Eugene 566
Moscow 550
São Paulo 450
Jakarta 449
Izmir 427
Rome 408
Munich 400
Shanghai 364
Boardman 322
North Bergen 322
Bologna 313
Toronto 303
Tokyo 300
Atlanta 296
Dublin 295
Salt Lake City 274
Frankfurt am Main 251
Phoenix 237
Orem 236
Belize City 233
Las Vegas 230
Redwood City 200
Brooklyn 196
Da Nang 193
Stanford 190
Montreal 181
Haiphong 171
San Francisco 164
Rio de Janeiro 160
Naples 158
Saint Augustine 156
Nuremberg 153
Denver 151
Boston 149
Washington 143
Florence 139
Mexico City 138
Redondo Beach 137
Warsaw 128
Kent 127
Amsterdam 120
Tampa 120
Miano 119
Baghdad 115
Guangzhou 115
San José 115
Norwalk 114
Parma 112
Reggio Emilia 112
Brasília 111
Porto Alegre 109
Elk Grove Village 108
Falls Church 106
Miami 106
Philadelphia 99
Bremen 98
Johannesburg 98
Belo Horizonte 97
Nanjing 96
Saint Louis 96
Charlotte 93
Totale 123.673
Salva come PNG Salva come JPEG
Nome #
64 Cu and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells 2.036
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.427
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria 594
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 540
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 524
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 487
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 486
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome 450
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 434
Visual loss and other cranial ischaemic complications in giant cell arteritis 420
Validation of the classification criteria for cryoglobulinaemic vasculitis 417
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience 412
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 407
Acute exacerbation of interstitial lung disease associated with rheumatic disease 402
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 396
Adult Primary Central Nervous System Vasculitis 382
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 380
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 379
Polymyalgia rheumatica 376
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 370
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 370
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 366
Retroperitoneal fibrosis 364
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 364
Clinical features of polymyalgia rheumatica and giant cell arteritis 358
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 358
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 354
2018 Update of the EULAR recommendations for the management of large vessel vasculitis 354
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 353
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 353
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 353
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 350
Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis 344
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 341
Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? 339
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 339
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 339
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 338
Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study 338
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 337
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations 337
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis 337
A comprehensive review on the role of mesenchymal stromal/stem cells in the management of rheumatoid arthritis 335
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 335
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients 334
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 333
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 329
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 326
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 326
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 325
Epidemiology of psoriatic arthritis 323
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 323
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 322
Polymyalgia rheumatica and giant-cell arteritis 320
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 320
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 320
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 318
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 317
Polymyalgia rheumatica 317
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 316
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 315
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 315
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 315
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 311
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 311
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 309
Unmet Needs in the Pathogenesis and Treatment of Vasculitides 309
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 306
Trial of Tocilizumab in Giant-Cell Arteritis 305
Biotherapies in large vessel vasculitis 304
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 303
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 302
Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients 301
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 301
EULAR guidelines on ANCA-associated vasculitis in the real life 301
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 300
2018 update of the EULAR recommendations for the management of Behçet's syndrome 300
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 297
Imaging of vasculitis: State of the art 295
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica 294
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 294
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 293
Anti-drug antibody detection with label-free electrolyte-gated organic field-effect transistors 293
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 291
Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: Correlation with positron emission tomography findings 291
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy 290
Comment on: Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature: Reply 290
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 290
Polymyalgia rheumatica and giant-cell arteritis 289
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 289
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 289
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 288
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 288
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 286
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 286
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases 284
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 284
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 284
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 283
Management of primary and secondary central nervous system vasculitis 283
Totale 36.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 744.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 744.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.785 0 0 0 0 369 965 861 631 1.513 943 2.021 1.482
2022/202310.863 1.386 756 738 798 1.307 1.559 243 1.046 1.697 225 597 511
2023/20248.281 335 532 425 849 1.815 486 515 1.469 246 216 374 1.019
2024/202527.322 1.171 353 400 2.006 4.686 4.221 1.655 1.346 3.413 2.340 2.535 3.196
2025/202653.816 3.024 2.054 4.895 5.202 4.608 4.222 6.900 3.197 6.762 4.095 4.632 4.225
2026/202721.099 2.609 4.596 5.263 7.485 1.146 0 0 0 0 0 0 0
Totale 184.003